Revolutionizing Bipolar Disorder Treatment with AL001 and Enhancing Corn Lines with Light Technology
Update: 2024-08-06
Description
In this episode, we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II clinical trial of AL001, a potential game-changer for bipolar disorder treatment. The study aims to establish AL001's safe, effective, and tolerable dosing requirements, potentially simplifying treatment regimens and improving patient compliance. We also explore the rising impact of mental health issues globally and how Alzamend Neuro is advancing new treatments for various conditions. Additionally, we cover BioLumic's innovative use of light to enhance inbred corn lines, with promising results and plans for commercialization in 2025.
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
